0.6055

6.70% -0.0435

Pre-market: .60 -0.0055 -0.91%

Prophase Labs Inc (PRPH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Prophase Labs Inc stock is traded at $0.6055, with a volume of 237.39K. It is down -6.70% in the last 24 hours and down -6.99% over the past month. ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Previous Close:

$0.649

Open:

$0.6295

24h Volume:

237.39K

Relative Volume:

0.98

Market Cap:

$14.46M

Revenue:

$62.71M

Net Income/Loss:

$-10.48M

P/E Ratio:

-0.9611

EPS:

-0.63

Net Cash Flow:

$-13.77M

1W Performance:

-15.34%

1M Performance:

-6.99%

6M Performance:

-81.62%

1Y Performance:

-87.64%

1-Day Range:

$0.58

$0.65

1-Week Range:

$0.56

$0.7256

52-Week Range:

$0.56

$7.48

Prophase Labs Inc Stock (PRPH) Company Profile

Name

Prophase Labs Inc

Sector

Healthcare (1191)

Industry

Diagnostics & Research (58)

Phone

(215) 345-0919

Address

711 STEWART AVE, SUITE 200, NEW YORK, PA

Employee

113

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

PRPH's Discussions on Twitter

Compare PRPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRPH Prophase Labs Inc	0.6055	14.46M	62.71M	-10.48M	-13.77M	-0.63
TMO Thermo Fisher Scientific Inc	556.99	213.05B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	237.62	171.63B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	143.43	40.54B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	197.96	35.93B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	418.63	34.28B	3.84B	866.24M	792.60M	10.37

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-20-21	Initiated	H.C. Wainwright	Buy
Oct-13-21	Downgrade	Dawson James	Buy → Neutral
Jan-20-21	Initiated	Dawson James	Buy

Prophase Labs Inc Stock (PRPH) Latest News

Jan 12, 2025

PRPH (ProPhase Labs) Debt-to-EBITDA : -1.36 (As of Sep. 2024) - GuruFocus.com

Jan 12, 2025

Jan 08, 2025

ProPhase Labs stock hits 52-week low at $0.61 amid sharp decline - Investing.com Canada

Jan 08, 2025

Dec 29, 2024

ProPhase Labs Receives Notice from NASDAQ Regarding Minimum Bid Price Requirement On December 26, 2024, ProPhase Labs, Inc. (NASDAQ: PRPH) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC, indicating that t - Defense World

Dec 29, 2024

Dec 28, 2024

ProPhase Labs faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria

Dec 28, 2024

ProPhase Labs faces potential Nasdaq delisting over share price - Investing.com

Dec 28, 2024

Dec 22, 2024

HighTower Advisors LLC Boosts Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World

Dec 22, 2024

Dec 20, 2024

ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline - Investing.com Australia

Dec 20, 2024

ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline By Investing.com - Investing.com South Africa

Dec 20, 2024

Dec 12, 2024

ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 11, 2024

ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline - Investing.com

Dec 11, 2024

ProPhase Labs secures private equity backing, nears lozenge deal, and plans cost-cutting measures - MSN

Dec 11, 2024

ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures - The Manila Times

Dec 11, 2024

ProPhase Labs Secures Global Private Equity Backing, Nears - GlobeNewswire

Dec 11, 2024

ProPhase Labs Secures Game-Changing Financing Deal, Eyes Major Asian Market Expansion - StockTitan

Dec 11, 2024

Dec 05, 2024

PRPH (ProPhase Labs) 5-Day RSI : 18.93 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Nov 27, 2024

ProPhase Labs Launches Genetic Testing Subsidiary with Advanced Technology - Precedence Research

Nov 27, 2024

Nov 26, 2024